Novel design principle validated: Glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent
| dc.contributor.author | Somsák, László | |
| dc.contributor.author | Nagy, Veronika | |
| dc.contributor.author | Vidal, Sébastien | |
| dc.contributor.author | Berzsényi, Eszter | |
| dc.contributor.author | Praly, Jean-Pierre | |
| dc.contributor.author | Czifrák, Katalin | |
| dc.date.accessioned | 2009-03-20T11:41:32Z | |
| dc.date.available | 2009-03-20T11:41:32Z | |
| dc.date.issued | 2008 | |
| dc.date.pasync | 2017-12-01T08:57:27Z | |
| dc.date.updated | 2017-12-01T08:57:27Z | |
| dc.identifier.citation | Bioorganic and Medicinal Chemistry Letters. -18 (2008), p. 5680-5683. -Bioorg. Med. Chem. - 0968-0896 | |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.bmcl.2008.08.052 | |
| dc.identifier.issn | 0968-0896 | |
| dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM004158 | hu |
| dc.identifier.original | http://www.sciencedirect.com/science/article/pii/S0960894X08009840 | |
| dc.identifier.uri | http://hdl.handle.net/2437/80409 | |
| dc.language | eng | |
| dc.rights.access | open access pre-print és post- print (24h embargó) | |
| dc.rights.owner | Elsevier | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject.mab | Természettudományok | |
| dc.subject.mab | Kémiai tudományok | |
| dc.title | Novel design principle validated: Glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent | |
| dc.type | folyóiratcikk |